Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07044557 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MeDex: No Perioperative Dexamethasone in Brain Metastases

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: May 1, 2026 to Aug 1, 2026v6
  2. Start date: Dec 3, 2025 to May 1, 2026v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 2026 to Dec 3, 2025
    v4
  4. Start date: Oct 2025 to Jan 2026
    • Eligibility criteria expanded, about 2 words
    v3
  5. Study description revisedv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Perioperative treatment of newly diagnosed cancer patients with brain metastasis without dexamethasone (Dex).
Trial Details
NCT Number NCT07044557
Lead Sponsor University of Louisville
Conditions
(from sponsor)		 Brain Metastases
Related terms Brain Neoplasms
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov